Tromsø, March 22nd 2023 - ArcticZymes Technologies ASA (OSE: AZT) announces that
the Board of Directors has today accepted the voluntary resignation of Jethro
Holter as Chief Executive Officer, due to personal reasons.

The resignation will take effect on 30th September 2023 after the required 6
months notice period.

 "On behalf of the Board, I want to thank Jethro very much for his outstanding
contributions to ArcticZymes over the past 3 years that he has served as our
CEO. During that time, Jethro has been instrumental in transforming ArcticZymes
into a successful and highly profitable business," said Marie Roskrow. "All of
the employees of ArcticZymes send their good wishes and thanks to Jethro."

The Board of Directors will immediately initiate a search for a new CEO. In the
meantime, Chairman of the Board, Marie Roskrow, will act as Executive Chairman
to lead and support the Company through this transition period.

ArcticZymes also anticipates expanding the Board of Directors in the near
future.

This information is considered to be inside information pursuant to the EU
Market Abuse Regulation and is subject to the disclosure requirements pursuant
to section 5-12 of the Norwegian Securities Trading Act.

The announcement was submitted for publication by Børge Sørvoll ,CFO at
ArcticZymes Technologies ASA, on 22 March 2023 at 10:20 CET.

For more information, please contact:

ArcticZymes Technologies
Chairman of the Board, Marie Roskrow      Tel: +44 (0) 7496 959 743
                                      marie.roskrow@arcticzymes.com

About ArcticZymes Technologies ASA

ArcticZymes Technologies is a Norwegian life sciences company focused on the
development, manufacturing and commercialization of novel recombinant enzymes
for use in molecular research, In Vitro Diagnostics (IVD) and biomanufacturing.

The company is listed on the Oslo Stock Exchange since 2005 as ArcticZymes
Technologies under the [AZT] ticker. Its headquarters are based in Tromsø,
Norway, at the SIVA Innovation Centre.

ArcticZymes Technologies' IP and capabilities are protected via a large
portfolio of patents.

For more information, please visit the website: www.arcticzymes.com.